公开(公告)号：US20140080869A1

公开(公告)日：2014-03-20

申请号：US14029324

申请日：2013-09-17

Applicant: AbbVie Inc.

Inventor： Preethi KRISHNAN ,  Teresa (Iok-Chan) NG ,  Tami J. PILOT-MATIAS ,  Warren M. KATI ,  Clarence J. MARING ,  Neeta C. MISTRY ,  Thomas J. REISCH ,  Rolf WAGNER ,  Dachun LIU ,  John K. PRATT ,  Mark A. Matulenko ,  Ryan G. KEDDY

IPC: A61K31/454 ,  A61K45/06

CPC classification number: A61K31/454 ,  A61K31/4184 ,  A61K45/06 ,  A61K2300/00

Abstract: Pan-genotypic HCV inhibitors are described. This invention also relates to methods of using these inhibitors to treat HCV infection.

公开(公告)号：US20140080868A1

公开(公告)日：2014-03-20

申请号：US14029302

申请日：2013-09-17

Applicant: AbbVie Inc.

Inventor： Theresea (Iok-Chan) NG ,  Tami J. PILOT-MATIAS ,  Warren M. KATI ,  Preethi KRISHNAN ,  Clarence J. MARING ,  Neeta C. MISTRY ,  Thomas J. REISCH ,  Rolf WAGNER ,  Dachun LIU ,  John K. PRATT ,  Mark A. MATULENKO ,  Ryan G. KEDDY

IPC: A61K31/454 ,  A61K45/06

CPC classification number: A61K31/454 ,  A61K31/4184 ,  A61K45/06 ,  A61P31/14 ,  A61K2300/00

Abstract: Pan-genotypic HCV inhibitors are described. This invention also relates to methods of using these inhibitors to treat HCV infection.

Abstract translation: 描述了泛基因型HCV抑制剂。 本发明还涉及使用这些抑制剂治疗HCV感染的方法。